Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Quanterix Community
NasdaqGM:QTRX Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Quanterix
Popular
Undervalued
Overvalued
Community Investing Ideas
Quanterix
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Simoa ONE Platform Will Revitalize Immunology And Oncology Markets
Key Takeaways Strategic product expansion and key acquisitions could significantly enhance market reach and revenue potential in immunology and oncology markets. Focus on diagnostics and recurring revenue streams is likely to improve profitability and operational efficiency, paving the way to positive cash flow.
View narrative
US$13.13
FV
55.2% undervalued
intrinsic discount
11.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
QTRX
QTRX
Quanterix
Your Fair Value
US$
Current Price
US$5.88
51.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-100m
247m
2015
2018
2021
2024
2025
2027
2030
Revenue US$247.2m
Earnings US$29.9m
Advanced
Set Fair Value